News
ACTG launches landmark study evaluating treatments for depressive disorders with or without mild neurocognitive disorder among people living with HIV
13+ hour, 48+ min ago (319+ words) European AIDS Treatment Group ACTG launches landmark study evaluating treatments for depressive disorders with or without mild neurocognitive disorder among people living with HIV CHAPEL HILL, N. C. , April 24, 2026 " ACTG, a global clinical trials network focused on HIV and other infectious diseases,…...